Too early to tell if injections are working
Prices vary depending on the specific drug, dosage, and pharmacy you use
The relationship observed between reductions in body weight and improvements in symptoms and physical limitations supports the hypothesis that the obesity phenotype of HFpEF is, in large part, a consequence of increased adiposity and its many sequelae, although there are also likely non-obesity-related contributors to the pathophysiology
Following these observations, clinical trials using GLP-1 therapies for the treatment of obesity showed stunning results, with treated patients losing an average of 12.4% of their initial body weight
After the introductory period, existing patients pay $349 per month for Ozempic 0.25 mg, 0.5 mg, or 1 mg and $499 per month for Ozempic 2 mg